The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(3-(4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazin-1-yl)propanamido)butyl)acrylamide ID: ALA4872089
PubChem CID: 164624328
Max Phase: Preclinical
Molecular Formula: C34H45N9O4
Molecular Weight: 643.79
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)NCCCCNC(=O)CCN1CCN(c2ccc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)nc2)CC1
Standard InChI: InChI=1S/C34H45N9O4/c1-4-29(45)35-14-7-8-15-36-30(46)13-16-41-17-19-42(20-18-41)26-11-12-28(37-21-26)39-34-38-22-27-23(2)31(24(3)44)33(47)43(32(27)40-34)25-9-5-6-10-25/h4,11-12,21-22,25H,1,5-10,13-20H2,2-3H3,(H,35,45)(H,36,46)(H,37,38,39,40)
Standard InChI Key: AKAKBFAHSQSEPO-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 51 0 0 0 0 0 0 0 0999 V2000
28.8369 -19.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8369 -19.8850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5422 -20.2895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5422 -18.6551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2475 -19.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2459 -19.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9501 -20.2905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6564 -19.8835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6541 -19.0650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9493 -18.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1298 -20.2946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5422 -17.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1280 -18.6613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1256 -17.8441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4215 -19.0719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5467 -21.1098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8863 -21.5911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1400 -22.3680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9573 -22.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2085 -21.5892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3645 -20.2914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0718 -19.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7783 -20.2926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4851 -19.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4847 -19.0659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7716 -18.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0677 -19.0691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1915 -18.6557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9001 -19.0626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1896 -17.8385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8963 -17.4282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6050 -17.8352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3117 -17.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6069 -18.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0204 -17.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7271 -17.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4358 -17.8286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7252 -16.6044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.1425 -17.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8512 -17.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5580 -17.4150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2666 -17.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9734 -17.4117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.6820 -17.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3888 -17.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0974 -17.8154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6839 -18.6358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 11 2 0
4 12 1 0
1 13 1 0
13 14 2 0
13 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
3 16 1 0
8 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
28 29 1 0
28 30 1 0
30 31 1 0
29 34 1 0
31 32 1 0
32 33 1 0
32 34 1 0
33 35 1 0
35 36 1 0
36 37 1 0
36 38 2 0
37 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 2 0
44 47 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 643.79Molecular Weight (Monoisotopic): 643.3595AlogP: 3.27#Rotatable Bonds: 14Polar Surface Area: 154.45Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.34CX Basic pKa: 7.87CX LogP: 2.64CX LogD: 2.04Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.14Np Likeness Score: -1.10
References 1. Shan H, Ma X, Yan G, Luo M, Zhong X, Lan S, Yang J, Liu Y, Pu C, Tong Y, Li R.. (2021) Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold., 219 [PMID:33857728 ] [10.1016/j.ejmech.2021.113432 ]